These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 6236125)

  • 1. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfloxacin for the treatment of uncomplicated urinary tract infections.
    Bailey RR; Peddie BA; Blake E
    N Z Med J; 1983 Jun; 96(733):446. PubMed ID: 6222277
    [No Abstract]   [Full Text] [Related]  

  • 4. Norfloxacin in acute urinary tract infections.
    Deaney NB; Vogel R; Vandenburg MJ; Currie WJ
    Practitioner; 1984 Jan; 228(1387):111-7. PubMed ID: 6229726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Norfloxacin sensitivity of bacterial pathogens of urinary tract infections].
    Modde H
    Schweiz Rundsch Med Prax; 1985 Apr; 74(17):439-42. PubMed ID: 3159064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Norfloxacin: a new oral chemotherapeutic agent effective against multi-drug-resistant Gram-negative bacteria and cocci. Rational directions for treatment].
    Panichi G; Magnanelli S; Giuliano M; Manzo M; Vetere A; Testore GP
    G Ital Chemioter; 1984; 31(1-2):65-71. PubMed ID: 6236125
    [No Abstract]   [Full Text] [Related]  

  • 7. The fluoroquinolones for urinary tract infections: a review.
    Cunha BA
    Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer carbapenems for urinary tract infections.
    Matsumoto T; Muratani T
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S35-8. PubMed ID: 15364304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of antibacterial agents of the nalidixic acid type.
    Albrecht R
    Prog Drug Res; 1977; 21():9-104. PubMed ID: 339272
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy reviews: nalidixic acid.
    Gleckman R; Alvarez S; Joubert DW; Matthews SJ
    Am J Hosp Pharm; 1979 Aug; 36(8):1071-6. PubMed ID: 384787
    [No Abstract]   [Full Text] [Related]  

  • 12. Norfloxacin: clinical pharmacology and clinical use.
    Rowen RC; Michel DJ; Thompson JC
    Pharmacotherapy; 1987; 7(4):92-110. PubMed ID: 3317294
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.